Member Info for Jace86

It may be the last time we see these prices. If revenues have grown and forecasts show it is to grow further then this will fly and eventually it will be bought out. Possibly by a tech giant. Wouldn't surprise me if Facebook themselves made a bid to monopolise their advertising revenues.

When everyones done getting spiked on EML...

"A bit like" does for me. Its not an exact science comment. Mirada would be the software that could power a content distributor. They have a long list of partners and clients. Worth a look on their site. Alot of big tech names and broadcasting corporations.

If progress has continued should show a re-rate on price once again. You sound like you are doing what I am Wress. At present 1.30 seems to be the floor and all it takes is one trade to put it up.

The volumes continue.

This morning. Should see a good re-rate.

With a bigger target audience!

Rise today obviously but in future it will... I think some users got culled by admin...

for 2p minimum. I suspect those buying have also seen the value...

Imagine the amount of checking theyd have to do. Would have to be done several times over so that they are 100% confident in their latest findings. I initially expected mid-end of June.

On HL I only see two... here I see three. The first one I reckon at 9:58 was a sell. Price dropped right after and the line was running at 1.85 so I assume 170-190 at the time of that. 10:40 Yeah - I'll go with that being a buy as it fits the trend and line at that time. 11:02 - Could be either. Price ticked up shortly after but immediately went back down. Either way this short term means nothing unless it remains a persistent buy or sell. It's only 3 trades. The next RNS is what matters.

Whopper of a sale! Now thats gone though...

One buy and one sell... someone took a minor loss?

Someone has took a 200 quid loss on this morning!

It just moves off buys and sells. Literally one trade will make it move up or down.

Right news or rumour - just look at mysq flying. They have had hard times too recently and turned a corner imo... This company could do similar.

Persistent and heavy buying. I'm liking what I am seeing and hope it turns well for all.

Cant see him/her... Admins been culling recently...

And at present thats what you are missing. There are hints that things didn't go to plan not with the drug but either production or testing. If it was that bad surely on ethical ground the japanese trial would have been suspended or stopped completely? It hasn't. There has been other comms and comments from their broker hinting at a different outcome post investigation. The advantage here is that there is another trial ongoing. Yes that may mean another european phase 3 trial should it be an error with the batch or testing. But thats why people are buying in at present. Yes it is a risk and yes in bio we need cold hard facts but if you have an opportunity to put something in here and you arent going to miss it, do it. Many anticipated June as being a point where news may drop where there would be an understanding of what went on. The key here is the other trial. This isn't like IMM where someone thinks it will get to market regardless of the flop it was and hoping the open label will prove something when there's no control element involved.

8 quid was the price without success. Phase 3 success the next step would be approval and then off to market. Unmet need in this drug and first mover advantage. Think of the very low number of shares in issue. Thats why I reckon 25 quid would come here. If patient, a hostile takeover would see an even greater return.